GB2465863A - Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections - Google Patents

Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections Download PDF

Info

Publication number
GB2465863A
GB2465863A GB0915258A GB0915258A GB2465863A GB 2465863 A GB2465863 A GB 2465863A GB 0915258 A GB0915258 A GB 0915258A GB 0915258 A GB0915258 A GB 0915258A GB 2465863 A GB2465863 A GB 2465863A
Authority
GB
United Kingdom
Prior art keywords
bacteria
resistant
alkoxy
substituted
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0915258A
Other languages
English (en)
Other versions
GB0915258D0 (en
Inventor
Daniel Chu
Tao Ye
Bing Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lead Therapeutics Inc
Original Assignee
Lead Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lead Therapeutics Inc filed Critical Lead Therapeutics Inc
Priority claimed from PCT/US2008/085716 external-priority patent/WO2009085562A1/en
Publication of GB0915258D0 publication Critical patent/GB0915258D0/en
Publication of GB2465863A publication Critical patent/GB2465863A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0915258A 2008-12-05 2008-12-05 Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections Withdrawn GB2465863A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2008/085716 WO2009085562A1 (en) 2007-12-26 2008-12-05 Novel semi-synthetic glycopeptides as antibacterial agents
US22016709P 2009-06-24 2009-06-24

Publications (2)

Publication Number Publication Date
GB0915258D0 GB0915258D0 (en) 2009-10-07
GB2465863A true GB2465863A (en) 2010-06-09

Family

ID=41203726

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0915258A Withdrawn GB2465863A (en) 2008-12-05 2008-12-05 Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections

Country Status (12)

Country Link
US (1) US20110015119A1 (https=)
EP (1) EP2373694A1 (https=)
JP (1) JP2012510999A (https=)
KR (1) KR20110099028A (https=)
CN (1) CN102307903A (https=)
AR (1) AR075354A1 (https=)
AU (1) AU2009322925A1 (https=)
CA (1) CA2745446A1 (https=)
GB (1) GB2465863A (https=)
IL (1) IL213390A0 (https=)
TW (1) TW201021805A (https=)
WO (1) WO2010065174A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140009A1 (en) * 2010-05-04 2011-11-10 Biomarin Pharmaceutical Inc. Methods of using semi-synthetic glycopeptides as antibacterial agents
CN107325159A (zh) 2016-04-29 2017-11-07 中国科学院上海药物研究所 一类万古霉素衍生物、其制备方法、药物组合物和用途
GB2577420B (en) 2017-05-22 2022-07-06 Insmed Inc Glycopeptide derivative compounds and uses thereof
CN109422800A (zh) * 2017-08-22 2019-03-05 复旦大学 抗革兰氏阳性菌季铵盐糖肽类化合物及其药用用途
CN111793076B (zh) * 2020-06-05 2021-10-12 华北制药河北华民药业有限责任公司 一种注射用硫酸头孢匹罗的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009085562A1 (en) * 2007-12-26 2009-07-09 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662674B2 (ja) * 1985-01-11 1994-08-17 三共株式会社 抗生物質クロロポリスポリンｂまたはｃ
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
NZ509165A (en) * 1998-07-14 2003-08-29 Univ Princeton Glycopeptide antobiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
DE69908819T2 (de) * 1998-12-23 2004-05-06 Theravance, Inc., South San Francisco Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
AU4054900A (en) * 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
MXPA02006029A (es) * 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos novedosos como agentes antibacterianos.
US6397405B1 (en) * 2000-04-11 2002-06-04 Thetford Corporation Flush toilet for RV's and boats
US6770621B2 (en) * 2000-05-02 2004-08-03 Theravance, Inc. Polyacid glycopeptide derivatives
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
US6620781B2 (en) * 2000-06-22 2003-09-16 Theravance, Inc. Glycopeptide carboxy-saccharide derivatives
US20030008812A1 (en) * 2001-02-02 2003-01-09 Christensen Burton G. Glycopeptide derivatives
TWI233932B (en) * 2001-08-24 2005-06-11 Theravance Inc Process for purifying glycopeptide phosphonate derivatives
US7521418B2 (en) * 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
CA2588285A1 (en) * 2004-11-29 2006-06-01 National University Corporation Nagoya University Glycopeptide antibiotic monomer derivatives
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US8236926B2 (en) * 2006-09-06 2012-08-07 Wisconsin Alumni Research Foundation Rapid glycopeptide optimization via neoglycosylation
WO2008075684A1 (ja) * 2006-12-19 2008-06-26 Shionogi & Co., Ltd. グリコペプチド抗生物質誘導体
GB2449156B8 (en) * 2007-05-08 2010-06-02 Lead Therapeutics Inc Semi-synthetic glycopeptides with antibacterial activity.
US20090062268A1 (en) * 2007-08-27 2009-03-05 Lead Therapeutics, Inc. Novel inhibitors of poly(adp-ribose)polymerase (parp)
US20100105607A1 (en) * 2008-10-24 2010-04-29 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
US20100216699A1 (en) * 2009-02-09 2010-08-26 Lead Therapeutics, Inc. Semi-synthetic glycopeptides having antibacterial activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009085562A1 (en) * 2007-12-26 2009-07-09 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents

Also Published As

Publication number Publication date
AU2009322925A1 (en) 2011-06-30
GB0915258D0 (en) 2009-10-07
KR20110099028A (ko) 2011-09-05
CA2745446A1 (en) 2010-06-10
AR075354A1 (es) 2011-03-30
US20110015119A1 (en) 2011-01-20
JP2012510999A (ja) 2012-05-17
IL213390A0 (en) 2011-07-31
TW201021805A (en) 2010-06-16
EP2373694A1 (en) 2011-10-12
WO2010065174A1 (en) 2010-06-10
CN102307903A (zh) 2012-01-04

Similar Documents

Publication Publication Date Title
US20120129763A1 (en) Novel semi-synthetic glycopeptides as antibacterial agents
JP2012509866A (ja) 抗菌活性を強化したランチビオティック型カルボキシアミド誘導体
US20080214444A1 (en) Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
WO2011140009A1 (en) Methods of using semi-synthetic glycopeptides as antibacterial agents
US7632918B2 (en) Semi-synthetic glycopeptides with antibiotic activity
US20090131304A1 (en) Semi-Synthetic Desmethyl-Vancomycin-Based Glycopeptides With Antibiotic Activity
GB2465863A (en) Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
US20100216699A1 (en) Semi-synthetic glycopeptides having antibacterial activity
GB2449156A (en) Semi-synthetic glycopeptides with antibacterial activity
US20120252741A1 (en) Novel semi-synthetic glycopeptides as antibacterial agents

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)